Published in Breast Cancer Res Treat on December 04, 2013
Considerations for observational research using large data sets in radiation oncology. Int J Radiat Oncol Biol Phys (2014) 2.06
Lobular breast cancer series: imaging. Breast Cancer Res (2015) 0.88
Importance of presurgical breast MRI in patients 60 years of age and older. J Clin Imaging Sci (2014) 0.75
Predicting associations between microRNAs and target genes in breast cancer by bioinformatics analyses. Oncol Lett (2016) 0.75
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med (2008) 11.16
Matching methods for causal inference: A review and a look forward. Stat Sci (2010) 9.78
Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet (2010) 4.79
Marginal structural models as a tool for standardization. Epidemiology (2003) 4.52
Variability in reexcision following breast conservation surgery. JAMA (2012) 3.26
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol (2008) 3.06
Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg (2009) 2.79
Identifying cancer relapse using SEER-Medicare data. Med Care (2002) 2.28
Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA (2003) 2.24
Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol (2008) 2.14
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer (1994) 2.06
Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer (2000) 1.97
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer (2008) 1.44
Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg (2013) 1.40
The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care (2011) 1.39
Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol (1993) 1.35
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat (2007) 1.31
Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg (2011) 1.25
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. Breast (2012) 1.20
Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev (2012) 1.20
Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer (2010) 1.19
The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol (2011) 1.17
Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast (2010) 1.16
Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res (2011) 1.08
The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat (2010) 1.07
Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol (2009) 1.05
Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol (2005) 1.04
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat (2008) 1.02
MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy? Ann Surg Oncol (2011) 1.02
Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol (2011) 1.01
Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. Eur J Surg Oncol (2004) 1.00
Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients. Ann Surg Oncol (2011) 1.00
Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat (2006) 0.99
Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery (2010) 0.96
Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer (2009) 0.95
Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery. Ann Surg Oncol (2012) 0.92
Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin N Am (2010) 0.91
Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol (2010) 0.87
Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer. Breast Cancer Res Treat (2013) 0.87
Variability of preoperative breast MRI utilization among older women with newly diagnosed early-stage breast cancer. Breast J (2013) 0.87
The challenge of developing quality measures for breast cancer surgery. JAMA (2012) 0.87
Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions? Ann Surg Oncol (2011) 0.79
The association of preoperative breast magnetic resonance imaging and multiple breast surgeries among older women with early stage breast cancer. Breast Cancer Res Treat (2013) 0.79
Pre-operative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer. Breast (2012) 0.78
Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction. Breast Cancer Res Treat (2012) 0.78
Nomogram for predicting positive resection margins after breast-conserving surgery. Breast Cancer Res Treat (2012) 0.77
Factors associated with breast MRI use: a population-based analysis. Ann Surg Oncol (2012) 0.76
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med (2003) 13.81
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol (2003) 9.72
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol (2013) 6.56
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA (2006) 6.45
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA (2012) 5.90
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst (2005) 5.55
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol (2006) 4.61
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol (2012) 3.63
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. J Clin Oncol (2008) 3.40
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst (2008) 2.94
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol (2005) 2.86
Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol (2003) 2.77
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72
Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Arch Pediatr Adolesc Med (2012) 2.70
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol (2005) 2.34
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol (2005) 2.20
Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Cancer (2010) 2.15
Adjuvant therapy of breast cancer in women 70 years of age and older: tough decisions, high stakes. Oncology (Williston Park) (2012) 2.13
Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl (2013) 2.07
Adjuvant chemotherapy of breast cancer in the older patient. Oncology (Williston Park) (2010) 2.03
Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst (2014) 1.96
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. J Clin Oncol (2007) 1.93
Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients. J Urol (2012) 1.81
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol (2011) 1.76
Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol (2011) 1.68
The "Welcome to Medicare" visit: a missed opportunity for cancer screening among women? J Womens Health (Larchmt) (2012) 1.65
Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol (2012) 1.61
Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy. JAMA Intern Med (2013) 1.60
Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina. Cancer (2013) 1.56
Choosing Healthplans All Together: a deliberative exercise for allocating limited health care resources. J Health Polit Policy Law (2005) 1.53
Will insured citizens give up benefit coverage to include the uninsured? J Gen Intern Med (2004) 1.49
Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist (2013) 1.49
Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer. Cancer (2014) 1.40
The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care (2011) 1.39
Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst (2012) 1.39
Assessing the feasibility of a virtual tumor board program: a case study. J Healthc Manag (2014) 1.39
Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. JAMA Psychiatry (2013) 1.38
Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes Control (2006) 1.38
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer (2005) 1.37
Estimating the Cost of Early Infant Male Circumcision in Zimbabwe: Results From a Randomized Noninferiority Trial of AccuCirc Device Versus Mogen Clamp. J Acquir Immune Defic Syndr (2015) 1.35
Community-based provision of injectable contraceptives in Madagascar: 'task shifting' to expand access to injectable contraceptives. Health Policy Plan (2011) 1.35
Insurance benefit preferences of the low-income uninsured. J Gen Intern Med (2002) 1.32
Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007. Radiology (2013) 1.30
Cost-effectiveness of adding bed net distribution for malaria prevention to antenatal services in Kinshasa, Democratic Republic of the Congo. Am J Trop Med Hyg (2009) 1.21
Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy Plan (2013) 1.20
Building community capacity to participate in cancer prevention research. Cancer Control (2006) 1.20
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. J Natl Cancer Inst (2013) 1.19
Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J (2006) 1.19
A qualitative study of perceived barriers to fruit and vegetable consumption among low-income populations, North Carolina, 2011. Prev Chronic Dis (2013) 1.19
Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer (2007) 1.17
Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA (2011) 1.15
"Not the 'grim reaper service'": an assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure. J Am Heart Assoc (2014) 1.14
Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat (2011) 1.13
Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control (2009) 1.12
Extended adjuvant endocrine therapy in breast cancer: current status and future directions. Clin Breast Cancer (2008) 1.11
Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. J Clin Oncol (2011) 1.11
Adapting clinical trials networks to promote cancer prevention and control research. Cancer (2006) 1.10
A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials. Clin Trials (2012) 1.09
Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res (2011) 1.08
The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy. Med Care (2008) 1.07
Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst (2012) 1.07
Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer (2013) 1.07
Human metapneumovirus and respiratory syncytial virus in hospitalized danish children with acute respiratory tract infection. Scand J Infect Dis (2004) 1.06
Recommendations for a global core curriculum in medical oncology. J Clin Oncol (2004) 1.06
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer (2012) 1.05
Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation. Med Care (2012) 1.05
Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf (2013) 1.05
Enrollees choose priorities for Medicare. Gerontologist (2004) 1.04
Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol (2014) 1.04
Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults. Cancer (2011) 1.04
Symptom management in metastatic breast cancer. Oncologist (2011) 1.03
Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin (2003) 1.02
Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol (2006) 1.02
A framework for understanding cancer comparative effectiveness research data needs. J Clin Epidemiol (2012) 1.00
Use and timeliness of radiation therapy after breast-conserving surgery in low-income women with early-stage breast cancer. Cancer Invest (2012) 1.00
The influence of aging on the early detection, diagnosis, and treatment of breast cancer. Curr Oncol Rep (2005) 1.00
An examination of Alzheimer's disease case definitions using Medicare claims and survey data. Alzheimers Dement (2010) 0.99
Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer. Breast Cancer Res Treat (2014) 0.97
Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden. Value Health (2011) 0.96
Racial difference in histologic subtype of renal cell carcinoma. Cancer Med (2013) 0.96
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Breast Cancer Res Treat (2006) 0.96
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients. Breast Cancer Res Treat (2012) 0.95
Examining potential colorectal cancer care disparities in the Veterans Affairs health care system. J Clin Oncol (2013) 0.95
The long-term cost effectiveness of treatments for benign prostatic hyperplasia. Pharmacoeconomics (2006) 0.92
Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review. Am J Public Health (2015) 0.92